Atrion Corporation Announces Election of New Director
August 30 2021 - 6:46PM
Atrion Corporation (NASDAQ: ATRI) today announced the election of
Maria Sainz as a director, effective immediately.
Ms. Sainz brings to our Board over 20 years of medical device
and management experience from both Silicon Valley start-ups and
large medical device companies. During the period from 2008 until
early this year, she served as the CEO of three innovative medtech
start-ups. One of these companies was acquired by CooperSurgical in
2021 and another was acquired by Stryker Corporation in 2011. At
Stryker, she led the Business Unit that comprised her former
company. From 1998 to 2006, Ms. Sainz held a number of leadership
positions at Guidant Corporation, including President of the
Cardiac Surgery division, Vice President, Global Marketing for the
Vascular Intervention division, and Vice President of the
Intermedics Cardiac Rhythm Management business in Europe. From 2006
to 2008, Ms. Sainz led integration activities following the
acquisition of Guidant by Boston Scientific.
Ms. Sainz serves as a director of two other public companies,
ShockWave Medical (SWAV) and Avanos Medical (AVNS). We are proud to
add Ms. Sainz to our Board.
Atrion Corporation develops and manufactures products primarily
for medical applications. The Company’s website is
www.atrioncorp.com.
Contact: |
Jeffery
Strickland |
|
Vice President and Chief Financial Officer |
|
(972) 390-9800 |
ATRION (NASDAQ:ATRI)
Historical Stock Chart
From Aug 2024 to Sep 2024
ATRION (NASDAQ:ATRI)
Historical Stock Chart
From Sep 2023 to Sep 2024